A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Mortality of People With Alzheimer's Disease and Psychiatric Morbidity: A Nationwide Finnish Cohort Study




TekijätAlastalo, Aleksi; Haapea, Marianne; Nordström, Tanja; Tolppanen, Anna‐Maija; Miettunen, Jouko; Nietola, Miika; Hartikainen, Sirpa; Jääskeläinen, Erika

Julkaisuvuosi2026

Lehti: International Journal of Geriatric Psychiatry

Artikkelin numeroe70210

Vuosikerta41

Numero4

ISSN0885-6230

eISSN1099-1166

DOIhttps://doi.org/10.1002/gps.70210

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1002/gps.70210

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/522994072

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä
Objectives

Psychiatric comorbidities are common in Alzheimer's disease (AD), and they have a negative impact on quality of life, but their impact on mortality remains unclear. This study examined mortality among persons with AD and psychiatric morbidity compared to persons with AD without psychiatric morbidity. This is the first study to analyze Alzheimer's disease mortality based on the timing of earlier psychiatric morbidity.

Methods

We utilized the nationwide register-based MEDALZ cohort, including 70,718 Finnish individuals diagnosed with AD between 2005 and 2011. Individuals were categorized into four groups based on the occurrence of their hospital-treated psychiatric diagnosis before the diagnosis of AD. Mortality was assessed over an 8-year follow-up. Chi-square test was used to compare the differences between the four groups in terms of causes of death and annual cumulative mortality. We determined cumulative mortality curves and hazard ratios, stratified by age, gender, cardiovascular disease, and the year of AD diagnosis.

Results

During the 8-year follow-up, 70.4% of the AD cohort had died. Persons with earlier psychiatric morbidity had an AD diagnosis 1.4–4.3 years earlier and died 1.4–4.1 years younger. Mortality risk was slightly higher among those with psychiatric morbidity compared to those without (adjusted HRs 1.03–1.41), with the effect decreasing over the years of follow-up. Mortality risk was not affected by the timing of psychiatric morbidity.

Conclusion

Psychiatric comorbidity is associated with earlier AD onset and reduced lifespan; however, post-diagnosis survival appears to be largely determined by AD progression itself.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This work was supported by a grant from the Academy of Finland (Grant No. 316563), Oulu University Hospital funding (basic government funding for hospitals), and Eka Grant from the Finnish Medical Foundation. The funders had no role in the study design, data collection, data analysis, interpretation of the results, or the decision to publish the article.


Last updated on